Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06555718
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-30
Brief Title:
Peer Support Program in Chronic Kidney Patient
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Examining the Effect of the Peer Support Program Applied to Chronic Kidney Patients on Care Outcomes
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main advantage of patient-to-patient peer counseling is that it benefits both the client and the peer mentors as real and authentic experiences are shared Since both individuals go through similar experiences they can share common feelings Although there are studies in the literature showing the effectiveness of peer support groups in different patient groups studies on chronic kidney disease patients are limited There are no studies on the effects of these programs on caregivers This study will be conducted to examine the effects of peer support program applied to chronic kidney patients on patient outcomes and caregivers
Detailed Description:
This study was planned to be conducted with a randomized controlled experimental design to examine the effect of the peer support program applied to Chronic Kidney patients on patient outcomes and caregivers
Patients diagnosed with Chronic Kidney Disease and receiving haemodialysis HD as a renal replacement method constitute the population of the study In the a priori power analysis performed to calculate the number of subjects the effect size was taken as 13 d based on reference studies Accordingly it was found that 34 subjects should be included in the calculation for the independent two-sample t-test according to 095 power and 005 alpha The sample of the study will consist of 25 intervention and 25 control CKDs who fulfil the inclusion criteria taking into account the dropout status
Patients diagnosed with Chronic Kidney Disease and receiving haemodialysis HD as a renal replacement method constitute the population of the study In the a priori power analysis performed to calculate the number of subjects the effect size was taken as 13 d based on reference studies Accordingly it was found that 34 subjects should be included in the calculation for the independent two-sample t-test according to 095 power and 005 alpha The sample of the study will consist of 25 intervention and 25 control CKDs who fulfil the inclusion criteria taking into account the dropout status
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None